Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of a state-wide neonatal screening programme.

E F Robertson, G N Hill, A C Pollard

    The Medical Journal of Australia
    |May 5, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The gridded retarding ion drift sensor for the petitSat cubeSat mission.

    The Review of scientific instruments·2020
    Same author

    Mr. Hill, on Cow-Pox.

    The Medical and physical journal·2018
    Same author

    To the Editors of the Medical and Physical Journal.

    The Medical and physical journal·2018
    Same author

    Mr. Hill, on Angina Pectoris.

    The Medical and physical journal·2018
    Same author

    Mr. Hill, on Medical Reform.

    The Medical and physical journal·2018
    Same author

    Mr. Hill, on the Liverpool Controversy.

    The Medical and physical journal·2018

    South Australia

    Area of Science:

    • Medical Genetics
    • Neonatal Screening
    • Public Health Programs

    Background:

    • Established newborn screening for phenylketonuria in South Australia.
    • Expanded screening to include galactosaemia, homocystinuria, hereditary tyrosinaemia, histidinaemia, maple syrup urine disease, and alpha 1-antitrypsin deficiency.
    • Subsequently added hypothyroidism screening.

    Purpose of the Study:

    • Evaluate the utility of expanded newborn screening tests.
    • Assess the effectiveness and impact of adding new screening panels.
    • Determine which screening tests provide clinical benefit.

    Main Methods:

    • Retrospective analysis of screening program data.
    • Inclusion of galactosaemia, homocystinuria, hereditary tyrosinaemia, histidinaemia, maple syrup urine disease, alpha 1-antitrypsin deficiency, and hypothyroidism.

    Related Experiment Videos

  • Monitoring of detection rates, repeat sample requests, and patient outcomes.

    • Main Results:

    • Galactosaemia and hypothyroidism screening proved beneficial additions.
    • Hereditary tyrosinaemia and alpha 1-antitrypsin deficiency screening led to repeat samples, anxiety, and no patient benefit.
    • Homocystinuria, maple syrup urine disease, and histidinaemia were not effectively detected or yielded low detection rates.

    Conclusions:

    • Galactosaemia and hypothyroidism screening are valuable components of the South Australian newborn program.
    • Screening for hereditary tyrosinaemia, alpha 1-antitrypsin deficiency, maple syrup urine disease, and histidinaemia was discontinued due to lack of benefit.
    • Current newborn screening in South Australia includes phenylketonuria, hypothyroidism, galactosaemia, and homocystinuria.